{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "91000980",
    "licUnit": "1",
    "validDate": "2026-02-18 00:00:00.000",
    "issueDate": "2021-02-18 00:00:00.000",
    "oriIssueDate": "2021-02-18",
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA09100098009",
    "prodNameC": "達沙替尼",
    "prodNameE": "Dasatinib",
    "indicationsName": [
        "白血病用藥"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": "",
            "packageUnit": "4C"
        }
    ],
    "medMCode": "01",
    "maMedCode": "",
    "medDCode": "E",
    "mainCategory": "E",
    "drBaseId": "B17D2241-A26C-417F-ABBE-53D09D7F8153",
    "subCategory": [],
    "ingredientsDesc": [
        "Dasatinib contains not less than 98.0% and not more than 102.0% of C22H26ClN7O2S‧H2O, calculated on anhydrous basis."
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "40 大陸生產"
    ],
    "applicantName": "新雙隆生技股份有限公司",
    "applicantAddr": "台北市松山區復興北路369號14樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "B17B509E-6258-4BAA-BAE0-3FA6FF680C2A",
            "factoryCode": "1",
            "factoryName": "HUBEI HAOSUN PHARMACEUTICAL CO., LTD.",
            "factoryAddr": "NO.20, JUXIAN ROAD, GEDIAN ECONOMIC & TECHNOLOGY DEVELOPMENT AREA, CHINA-436070, EZHOU, HUBEI PROVINCE, CHINA",
            "factoryCompanyAddr": null,
            "countryCode": "CN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FCN0343100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsName": "Dasatinib contains not less than 98.0% and not more than 102.0% of C22H26ClN7O2S‧H2O, calculated on anhydrous basis.",
            "ingredientsDesc": "Dasatinib contains not less than 98.0% and not more than 102.0% of C22H26ClN7O2S‧H2O, calculated on anhydrous basis.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EA02"
        }
    ],
    "licBaseId": "CEBD65F2-7665-4850-A147-6CAE2CC1A995"
}